BioSpace News Archive

Anixa Biosciences, Inc. (NASDAQ: ANIX) (“Anixa”), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the China National Intellectual Property Administration (CNIPA) has issued a Notification of Grant of Patent Right on Anixa’s novel Chimeric Antigen Receptor-T cell (CAR-T).

Natera, Inc. announced the completion of the VALID Study for Prospera™ in lung transplant recipients.

Moderna, Inc. today announced the launch of the Moderna Fellowship Program.

Tenax Therapeutics, Inc. today announced that the FDA has reviewed and cleared its Investigational New Drug (IND) application for a novel formulation of imatinib.

Globe Scientific, a producer of reliable laboratory plastics, glass and equipment for scientific, education, clinical and specialty markets introduces Diamond® PureFlow™ Syringe Filters to their product line.

Brain-assessment device innovator BrainScope, and Aon plc (NYSE: AON), a leading global professional services firm, today announced the completion of an intellectual property-based funding arrangement.

Targovax ASA, a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, announces that two abstracts has been accepted for poster presentation at the Society for Immunotherapy of Cancer Annual Meeting.

Precision Optics Corporation, Inc., a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday, October 7, 2021 at 4:15pm ET.

Heat Biologics, Inc. today announced the appointment of Paul Tebbey, Ph.D. as Senior Vice President of Product Development and Portfolio Strategy.

Intellia Therapeutics, Inc. today announced the authorization of its Clinical Trial Application (CTA) by the New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) to initiate a Phase 1/2 study evaluating NTLA-2002 for the treatment of adults with hereditary angioedema (HAE).